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Vpr makes holes
 
he Vpr protein from HIV-1 makes holes in the nucleus, 
according to Warner Greene (Gladstone Institute of Virology 
and Immunology, University of California, San Francisco, CA) 
and colleagues. The holes allow the mixing of proteins that are 
usually exclusively nuclear or cytoplasmic. The damage, the 
mixing, or both may cause a G2 cell cycle arrest that allows the 
virus to replicate more efficiently.
For some time Greene has been studying the ability of Vpr to 
arrest the cell cycle. Vpr shuttles into the nucleus, so Greene 
suspected that it could affect the shuttling of other proteins. But 
protein-localization studies on populations of infected cells 
yielded inconsistent, fluctuating results that could not be 
reproduced. So Greene suggested single cell studies, the results 
of which are presented by de Noronha et al.
They find that cells expressing Vpr suffer from occasional 
herniations in their nuclear envelopes. The herniations are 
large enough to allow the passage not only of proteins but also 
entire virus particles. “It’s very reminiscent of a solar flare,” 
says Greene. “Some herniations can occupy up to 5 or 10% of 
the circumference of the nuclear envelope, and they are very 
dynamic.”
Two proteins that change their distribution after the herniations 
are Wee1 (which is normally nuclear) and Cdc25C (which is 
normally cytoplasmic). Both proteins regulate the phosphorylation 
status of the cell cycle kinase Cdc2, which starts off in an 
inhibited, phosphorylated state in the nucleus thanks to Wee1, 
before moving to the cytoplasm where it is activated by 
Cdc25C dephosphorylation. Vpr may induce G2 arrest either 
by releasing the inhibitory Wee1 into the cytoplasm, or by 
allowing some other change in enzyme localization.
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A TORriﬁc ATP sensor
 
positive regulator of growth called 
mTOR (mammalian Target of 
Rapamycin) is a direct detector of ATP 
levels, according to George Thomas 
(Friedrich Miescher Institute for 
Biomedical Research, Basel, Switzerland) 
and colleagues. This connection from 
ATP to growth may explain why certain 
oxygen- and ATP-starved tumor cells are 
particularly sensitive to the mTOR-
inhibitor rapamycin, as such tumors, 
through increased glycolysis and ATP 
production, may use the mTOR signaling 
pathway to proliferate.
Dennis et al. began their studies with 
mTOR kinase assays. Results in several 
labs had been spotty, to the extent that 
mTOR’s qualifications as a kinase were 
in question. “We were about ready to 
toss it out,” says Thomas.
A
All roads lead to TOR.
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Alternatively, the cell cycle may halt in response to the 
structural damage induced by Vpr. Based on the disruption 
of nuclear lamin organization, de Noronha suggest that Vpr 
may interfere with nuclear lamin interactions, although a 
direct binding event has yet to be demonstrated.
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Nuclear holes allow Wee1 to escape (top, left to right) 
and Cdc25C to enter (bottom) the nucleus.
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But, by chance, the authors discov-
ered that higher ATP concentrations 
converted mTOR into a robust kinase. 
Dropping ATP levels in vitro, or adding 
glycolytic inhibitors in vivo resulted in a 
drop in mTOR-specific phosphorylations 
of target proteins.
Apparently mTOR can act as a cellular 
ATP sensor because it has a weak, 
millimolar affinity for ATP. When both 
ATP and amino acids are available, 
mTOR upregulates translation and 
ribosome biogenesis, and downregulates 
autophagy. The remaining question is 
whether cancer cells that have gained 
a selective growth advantage by 
boosting mTOR activity do so through 
raising intracellular ATP levels. 
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